Abstract
Purpose. We examined the functional properties of choline transport across the blood-brain barrier (BBB) in mice. We compared the kinetic parameters and transport properties with those found in our in vitro uptake experiments using mouse brain capillary endothelial cells (MBEC4).
Methods. The permeability coefficient-surface area product (PS) values of [3H]choline at the BBB were estimated by means of anin situ brain perfusion technique in mice.
Results. [3H]Choline uptake was well described by a two-component model: a saturable component and a nonsaturable linear component. The [3H]choline uptake was independent of pH and Na+, but was significantly decreased by the replacement of Na+ with K+. Various basic drugs, including substrates and inhibitors of the organic cation transporter, significantly inhibited the [3H]choline uptake. These in situ (in vivo) results corresponded well to the in vitro results and suggest that the choline transporter at the BBB is a member of the organic cation transporter (OCT) family.
Conclusion. The choline transport mechanism at the BBB is retained in MBEC4.
Similar content being viewed by others
REFERENCES
R. Spector. Micronutrient homeostasis in mammalian brain and cerebrospinal fluid. J. Neurochem. 53:1667–1674 (1989).
J. K. Blusztajn and R. J. Wurtman. Choline and cholinergic neurons. Science 221:614–620 (1983).
R. J. Wurtman. Choline metabolism as a basis for the selective vulnerability of cholinergic neurons. Trends Neurosci. 15:117–122 (1992).
E. M. Cornford, L. D. Braun, and W. H. Oldendorf. Carrier mediated blood-brain barrier transport of choline and certain choline analogs. J. Neurochem. 30:299–308 (1978).
N. Sawada, H. Takanaga, H. Matsuo, M. Naito, T. Tsuruo, and Y. Sawada. Choline uptake by mouse brain capillary endothelial cells in culture. J. Pharm. Pharmacol. 51:847–852 (1999).
T. Tatsuta, M. Naito, K. Mikami, and T. Tsuruo, Enhanced expression by the brain matrix of P-glycoprotein in brain capillary endothelial cells. Cell Growth Differentiation 5:1145–1152 (1994).
H. Murakami, H. Takanaga, H. Matsuo, H. Ohtani, and Y. Sawada. Comparison of blood-brain barrier permeability in mice and rats using in situ brain perfusion technique. Am. J. Physiol. in press (2000).
K. Yamaoka, Y. Tanigawara, T. Nakagawa, and T. Uno. A pharmacokinetic analysis program (multi) for microcomputer. J. Pharmacobio-Dyn. 4:879–885 (1981).
I. Tamai, and A. Tsuji. Carrier-mediated approaches for oral drug delivery. Drug. Deliv. Rev. 19:401–424 (1996).
B. Giros, S. El Mestikawy, L. Bertrand, and M. G. Caron. Cloning and and functional characterization of a cocaine-sensitive dopamine transporter. FEBS Lett. 295:149–154 (1991).
A. S. Chang, S. M. Chang, D. M. Starnes, S. Schroeter, A. L. Bauman, and R. D. Blakely. Cloning and expression of the mouse serotonin transporter. Mol. Brain Res. 43:185–192 (1996).
J. Masson, C. Sagne, M. Hamon, and S. El Mestikawy. Neurotransmitter transporters in the central nervous system. Pharm. Rev. 51:439–464 (1999).
B. M. Cohen, P. F. Renshaw, A. L. Stoll, R. J. Wurtman, D. Yurgelun-Todd, and S. M. Babb. Decreased brain choline uptake in older adults. An in vivo proton magnetic resonance spectroscopy study. JAMA 274:902–907 (1995).
J. Klein, A. Koppen, and K. Loffelholz. Uptake and storage of choline by rat brain: influence of dietary choline supplementation. J. Neurochem. 57:370–375 (1991).
J. Klein, A. Koppen, K. Loffelholz, and J. Schmitthenner. Uptake and metabolism of choline by rat brain after acute choline administration. J. Neurochem. 58:870–876 (1992).
D. Grundemann, V. Gorboulev, S. Gambaryan, M. Veyhl, and H. Koepsell. Drug excretion mediated by a new prototype of polyspecific transporter. Nature 372:549–552 (1994).
M. Okuda, H. Saito, Y. Urakami, M. Takano, and K. Inui. cDNA cloning and functional expression of a novel rat kidney organic cation transporter, OCT2. Biochem. Biophys. Res. Commun. 224: 500–507 (1996).
R. Kekuda, P. D. Prasad, X. Wu, H. Wang, Y-J. Fei, F. H. Leibach, and V. Ganapathy. Cloning and functional characterization of a potential-sensitive, polyspecific organic cation transporter (OCT3) most abundantly expressed in placenta. J. Biol. Chem. 273:15971–15979 (1998).
I. Tamai, H. Yabuuchi, J. Nezu, Y. Sai, A. Oku, M. Shimane, and A. Tsuji. Cloning and characterization of a novel human pHdependent organic cation transporter, OCTN1. FEBS Lett. 419: 107–111 (1997).
I. Tamai, R. Ohashi, J. Nezu, H. Yabuuchi, A. Oku, M. Shimane, Y. Sai, and A. Tsuji. Molecular and functional identification of sodium ion-dependent, high affinity human carnitine transporter OCTN2. J. Biol. Chem. 273:20378–20382 (1998).
I. Tamai, R. Ohashi, M. Katsura, K. Sakamoto, K. China, K. Yamaguchi, J. Nezu, A. Oku, M. Shimane, Y. Sai, and A. Tsuji. Multiplicity of functional characterization and tissue distribution of OCTN-transporter family. Xenobio. Metabol. Dispos. 14(suppl.): S114–S115 (1999).
A. E. Busch, S. Quester, J. C. Ulzheimer, V. Gorboulev, A. Akhoundova, S. Waldegger, F. Lang, and H. Koepsell. Monoamine neurotransmitter transport mediated by the polyspecific cation transporter rOCT1. FEBS Lett. 395:153–156 (1996a).
A. E. Busch, U. Karbach, D. Miska, V. Gorboulev, A. Akhoundova, C. Volk, P. Arndt, J. C. Ulzheimer, M. S. Sonders, C. Baumann, S. Waldegger, F. Lang, and H. Koepsell. Human neurons express the polyspecific cation transporter hOCT2, which translocates monoamine neurotransmitters, amantadine, and memantine. Mol. Pharmacol. 54:342–352 (1998).
D. Grundemann, S. Koster, N. Kiefer, T. Breidert, M. Engelhardt, F. Spitzenberger, N. Obermuller, and E. Schomig. Transport of monoamine transmitters by the organic cation transporter type 2, OCT2. J. Biol.Chem. 273:30915–30920 (1998).
A. E. Busch, S. Quester, J. C. Ulzheimer, S. Waldegger, V. Gorboulev, P. Arndt, F. Lang, and H. Koepsell. Electrogenic properties and substrate specificity of the polyspecific rat cation transporter rOCT1. J. Biol. Chem. 271:32599–32064 (1996b).
M. Okuda, Y. Urakami, H. Saito, and K. Inui. Molecular mechanisms of organic cation transport in OCT2-expressing Xenopus oocytes. Biochim. Biophys. Acta 1417:224–231 (1999).
X. Wu, R. Kekudam, W. Huang, Y-J. Fei, F. H. Leibach, J. Chen, S. J. Conway, and V. Ganapathy. Identity of the organic cation transporter OCT3 as the extraneuronal monoamine transporter (uptake2) and evidence for the expression of the transporter in the brain. J. Biol. Chem. 273:32776–32786 (1998).
X. Wu, W. Huang, P. D. Prasad, P. Seth, D. P. Rajan, F. H. Leibach, J. Chen, S. J. Conway, and V. Ganapathy. Functional characteristics and tissue distribution pattern of organic cation transporter 2 (OCTN2), an organic cation/carnitine transporter. J. Pharmacol. Exp. Ther. 290:1482–1492 (1999).
H. Yabuuchi, I. Tamai, J. Nezu, K. Sakamoto, A. Oku, M. Shimane, Y. Sai, and A. Tsuji. Novel membrane transporter OCTN1 mediates multispecific, bidirectional, and pH-dependent transport of organic cations. J. Pharmacol. Exp. Ther. 289:768–773 (1999).
Y. Miyamoto, V. Ganapathy, and F. H. Leibach. Transport of guanidine in rabbit intestinal brush-border membrane vesicles. Am. J. Physiol. 255:G85–92 (1988).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Murakami, H., Sawada, N., Koyabu, N. et al. Characteristics of Choline Transport Across the Blood-Brain Barrier in Mice: Correlation with In Vitro Data. Pharm Res 17, 1526–1530 (2000). https://doi.org/10.1023/A:1007613326759
Issue Date:
DOI: https://doi.org/10.1023/A:1007613326759